Cargando…

Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy

[Figure: see text]

Detalles Bibliográficos
Autores principales: Ley, Klaus, Roy, Payel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352285/
https://www.ncbi.nlm.nih.gov/pubmed/34396272
http://dx.doi.org/10.1016/j.jaccao.2020.08.008
_version_ 1783736147951747072
author Ley, Klaus
Roy, Payel
author_facet Ley, Klaus
Roy, Payel
author_sort Ley, Klaus
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-8352285
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83522852021-08-13 Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy Ley, Klaus Roy, Payel JACC CardioOncol Original Research [Figure: see text] Elsevier 2020-10-06 /pmc/articles/PMC8352285/ /pubmed/34396272 http://dx.doi.org/10.1016/j.jaccao.2020.08.008 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Ley, Klaus
Roy, Payel
Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy
title Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy
title_full Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy
title_fullStr Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy
title_full_unstemmed Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy
title_short Blind Spot: (18)F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy
title_sort blind spot: (18)f-fdg pet fails to reveal atherosclerosis aggravated by cancer immunotherapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352285/
https://www.ncbi.nlm.nih.gov/pubmed/34396272
http://dx.doi.org/10.1016/j.jaccao.2020.08.008
work_keys_str_mv AT leyklaus blindspot18ffdgpetfailstorevealatherosclerosisaggravatedbycancerimmunotherapy
AT roypayel blindspot18ffdgpetfailstorevealatherosclerosisaggravatedbycancerimmunotherapy